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ABSTRACT 
Background: Despite immense interest, robotic-assisted thyroidectomy (RT) remains 
controversial in differentiated thyroid carcinoma (DTC). This systematic review and meta-
analysis compared surgical completeness and/or oncological outcomes between RT and open 
thyroidectomy (OT) in low-risk DTC. 
Methods: A systematic review was performed to identify studies that compared surgical 
completeness and/or oncological outcomes between RT and OT in DTCs. Any study that 
compared at least one parameter relating to surgical completeness and /or oncological outcome 
for DTC was considered. Number of central lymph nodes (CLNs) retrieved during central neck 
dissection (CND), pre-ablation stimulated thyroglobulin (sTg) level, radioiodine uptake on post-
therapy scan and locoregional recurrence (LRR) were examined. Meta-analysis was performed 
using a fixed or random-effect model depending on heterogeneity between studies. 
Results:  Ten studies were eligible. Of the 2205 DTCs, 752 (34.1%) had RT while 1453 (65.9%) 
had OT. Relative to OT, RT had significantly fewer CLNs retrieved during CND (4.7 ± 3.2 vs. 
5.5 ± 3.8, SMD=-0.240,95%CI=-0.364 - -0.116, p<0.001) and higher pre-ablation sTg level (3.6 
± 6.7ng/mL vs. 2.0 ± 5.0ng/mL, SMD=0.272,95%CI=0.022 – 0.522,p=0.033). Interestingly, 
these differences were more evident in the robotic transaxillary approach (RTAA) than the 
robotic bilateral axillo-breast approach. After a mean follow-up of 17.7 months, no LRR was 
found in RT while after 18.6 months, 1 LRR was found in OT. 
Conclusions: Relative to OT, total thyroidectomy by RTAA was associated with fewer CLNs 
retrieved and less-complete thyroid resection. However, using RTAA is unlikely to compromise 
the outcomes of low-risk DTC because of its inherently good prognosis.
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INTRODUCTION 
Thyroidectomy is a common surgical procedure and the standard cervical open thyroidectomy 
(OT) has been proven safe and effective under experienced hands [1]. However, to further 
improve the cosmetic result and increase patient satisfaction, endoscopic approaches with 
incisions made outside the neck (also known as the extracervical approaches) were developed 
[2,3]. In 2007, a South Korean group pioneered using the da Vinci robot (the so-called “robotic-
assisted thyroidectomy” or RT) to improve the ergonomics of these extracervical approaches [4]. 
Currently, the two most-described approaches are the robotic transaxillary approach (RTAA) and 
the robotic bilateral axillo-breast approach (RBA) [3]. Despite the higher cost, the proponents 
view that RT offers improved motion of endoscopic instruments, clearer stereoscopic visual field 
and dampening of physiologic tremors [4]. Since the first report in 2009,[5] there has been 
immense interest both in the US and other parts of the world with various groups publishing their 
initial successful experience [6-9]. However, RT remains controversial. In October 2011, the 
Food and Drug Administration in the US revoked the approval on the use of the robot in 
thyroidectomy and parathyroidectomy [10]. 
Although recent meta-analyses have found that both RT and OT may have comparable surgical 
medium to long term outcomes,[11-13] it remains unclear whether RT could provide a similar 
level of surgical completeness and oncological outcome as the gold standard OT in the treatment 
of differentiated thyroid carcinoma (DTC). This is relevant because in some parts of the world, 
this procedure is done mostly for low-risk DTC [4,5]. To our knowledge, there have been a few 
single-institution studies specifically evaluating these aspects [14,15]. However, as with any 
meta-analysis, one major advantage of pooling data from various studies is that at times it could 
highlight interesting and important findings which may not be apparent with individual study due 
4 
 
to the lack of power. Therefore, we conducted a systematic review and meta-analysis to compare 
surgical completeness and/or oncological outcomes between RT and OT. 
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METHODS 
This systematic review and meta-analysis was conducted in accordance with the PRISMA 
statement[16]. 
Search strategy 
Studies comparing surgical completeness +/- oncological outcomes between patients with DTC 
who underwent RT and OT were retrieved from the Scopus, Medline (PubMed) and Cochrane 
Library electronic databases on 20th February 2014. We used the following free text search terms 
in “All fields” 
#1: ‘robotic thyroidectomy’  
#2: ‘robotic assisted thyroidectomy’ 
#3: ‘robot thyroidectomy’ 
#4: #1 OR #2 OR #3 
There was no language restriction or methodological filters. The bibliographies of two previous 
meta-analyses on RT were searched for other additional relevant references [11,12]. 
Study selection 
All titles identified by the search strategy were screened independently by three authors (BHL, 
JST, KPW). Search results were compared, and disagreements were resolved by consensus. 
Abstracts of potentially relevant titles were then reviewed for eligibility and full-length articles 
were selected for closer examination. Any prospective or retrospective study that compared at 
least one variable on surgical completeness and /or oncological outcome for DTC was 
considered. These variables included number of central lymph nodes (CLNs) retrieved during 
surgery, postoperative stimulated thyroglobulin (sTg) levels, findings on post-therapy 
radioiodine scan (RxWBS) and locoregional recurrence (LRR). However, we excluded case 
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reports, editorials, expert opinions, reviews without original data, studies on pediatric population, 
studies comparing outcomes between RT and endoscopic (i.e. non-robotic) thyroidectomy and 
studies evaluating patients undergoing robotic-assisted lateral neck dissection. For studies with 
limited data on sTg, LRR and follow-up duration, the corresponding author of those studies was 
individually contacted for further information. Multiple reports of the same dataset were assessed 
and the most representative or updated report of a study was included.  
Data extraction 
All data were extracted onto a standardized form. The primary data extracted from each article 
included: type or design of study, first authorship, country of origin, year of publication, patient 
demographics, patient selection for RT and OT, extent of surgery (total thyroidectomy (TT) or 
less than total thyroidectomy (LTT)), tumor characteristics such as histological type, presence of 
extrathyroidal extension, multicentricity and bilaterality, tumor size, CLN metastasis, number of 
CLNs retrieved, TNM stage, pre-ablative sTg, percentage of radioactive iodine uptake (RAIU) 
on RxWBS, locoregional recurrence (LRR) and follow-up duration (months). TT included near-
TT, TT and TT with central neck dissection (CND) whereas LTT included hemithyroidectomy 
and subtotal thyroidectomy. 
Study quality 
The quality of all non-randomized studies was assessed using the Newcastle–Ottawa Scale 
(NOS)[17]. The NOS considers methods of patient selection, comparability of the study groups 
and reporting of important outcomes. A maximum rating of 9 may be given to individual studies. 
Studies achieving a rating of 5 or more were considered higher quality. Two reviewers (BHL, 
JST) independently assessed the quality of the studies and disagreement was resolved by 
consensus. 
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Statistical methods 
For comparison of dichotomous variables between RT and OT, chi-square tests and Fisher’s 
exact tests were used. Student t-test was used for comparison of continuous variables. All the 
individual outcomes were integrated with the meta-analysis software Review Manager Software 
5.0 (Cochrane Collaborative, Oxford, England). Standardized mean differences (SMD) were 
calculated for tumor size, number of CLNs retrieved, postoperative sTg level and RAIU. Odds 
ratios (OR) were examined for other categorical characteristics and outcomes. Heterogeneity was 
assessed with Cochran's Q statistic (chi-square), with a p value <0.10 for significance, and with 
the I2 test.[18] An I2 value >50% was considered substantial heterogeneity. Results were 
aggregated and analyzed using a fixed-effect model if I2 value was not ≤50%. For I2 values >50%, 
results were analyzed using a random-effect model. Publication bias was estimated by Begg’s 
rank correlation test and Egger’s regression test [19]. The meta-analyses in this study were 
conducted using IBM SPSS Version 20.0 for Window and Comprehensive Meta-Analysis 
Version 2.2.064 (Biostat, Inc.).
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RESULTS 
Figure 1 shows the flowchart of studies retrieved and excluded. Of the 485 titles initially 
identified from the database search, 20 full-length articles were assessed for inclusion, of which 
10 were excluded and 10 studies [14,15,20-27] were determined to be eligible and were included 
in this systematic review. Table 1 lists these 10 excluded articles [28-37] and the reason for their 
exclusion. No additional study was found from our search of the two bibliographies in previous 
meta-analyses.[11,12] Of these 10 articles excluded, 5 were excluded mainly because their data 
were superseded by later studies.[19,22-24] 
Patient selection  
Ultrasonography was used as routine preoperative imaging modality in all studies.[14,15,20-27] 
The inclusion and exclusion criteria for RT or OT were similar. Inclusions included patient age 
between 21 – 65 years old, size of DTC ≤ 2 – 4 cm, thyroid lobe size ≤ 6cm and body mass index 
≤ 36.[14,15,20-27] Exclusions included previous neck irradiation, presence of lateral lymph node 
and distant metastases, and posteriorly located carcinoma.[20,23,24,26] In terms of selecting for 
RT or OT, 4 studies were based on patient preference[14,20,25,27] while the other 6 studies did 
not specify their selection method.[15,21-24,26] In one study,[21] patients in the OT group were 
selected in reverse, chronological consecutive order from the time when the robot was first 
implemented (i.e. historical controls) while the others were cohort in design. 
Baseline characteristics  
Table 2a shows a comparison of the baseline characteristics between the 10 eligible studies. 
There were no randomized trials. Eight studies were retrospective while two were prospective. 
Of the 2205 patients included, 752 (34.1%) had RT (RT group) while 1453 (65.9%) had OT (OT 
group). In the RT group, there were 522 TTs and 230 LTTs while in the OT group, there were 
9 
 
1235 TTs and 218 LTTs. Overall, the OT group had significantly a higher TT:LTT ratio than the 
RT group (1235:218 vs. 522:230, p<0.001). Eight studies evaluated RTAA [14,20-25,27] while 
2 studies evaluated RBA[15,26]. Of the 10 studies, two were from the United States while the 
rest came from South Korea. 
Age at operation was matched in 3 studies [20,21,24] while sex ratio was matched in 4 studies 
[20,21,24,25]. Overall, patients in RT were significantly younger (40.8 ± 8.6 vs. 50.3 ± 10.7 
years old, p<0.001) and more likely females (644:50 vs. 1192:186, p<0.001) than OT. In terms 
of histological types, 8 studies[14,15,20,22,23,25-27] exclusively had PTC while 2 had both PTC 
and FTC [21,24]. Overall, FTC only accounted for 0.2% of the entire DTC cohort. 
After checking the heterogeneity using p-value of χ2 (p-value of <0.1) and I2, five 
characteristics/outcomes were considered to have significant heterogeneity between studies and 
they were tumor multicentricity, χ2=19.167, df=6, p=0.004, I2=68.696%; bilaterality, χ2=13.652, 
df=6, p=0.034, I2=56.050%; TNM stage, χ2=19.077, df=6, p=0.004, I2=68.549%; sTg, χ2=21.954, 
df=5, p=0.001, I2=77.225%; Post Scan, χ2=140.373, df=2, p<0.001, I2=98.575%. 
Tumor characteristics  
Table 2b shows a comparison of tumor characteristics between RT and OT. There were no 
significant differences in the proportion of extrathyroidal extension (348/582 (59.8%) vs. 
710/1203 (59.0%),OR=0.963, 95%CI=0.774 – 1.197, p=0.732), tumor multi-centricity (200/668 
(29.9%) vs. 438/1291 (33.9%), OR=0.822, 95%CI=0.535 – 1.261, p=0.368) and bilaterality 
(121/442 (27.4%) vs. 276/1076 (25.7%), OR=1.092, 95%CI=0.675 – 1.766, p=0.721) between 
the two groups. The mean primary tumor size in RT was significantly smaller than OT (7.7 ± 
3.3mm vs. 8.6 ± 4.6mm) (SMD=-0.198; 95%CI=-0.297 - -0.098, p<0.001). Among the 7 studies 
reporting the number of CLNs retrieved during surgery, unilateral CND was performed in all 7 
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studies [14,20,22,23,25-27]. Figure 2a shows the forest plot for number of CLNs retrieved. The 
mean number of CLNs retrieved in RT was significantly less than OT (4.7 ± 3.2 vs. 5.5 ± 3.8) 
(SMD=-0.240, 95%CI=-0.364 - -0.116, p<0.001). Interestingly, this difference was more 
noticeable in the RTAA subgroup analysis (4.7 ± 3.3 vs. 5.7 ± 4.0, SMD=-0.283, 95%CI=-0.412 
- -0.154, p<0.001) than the RBA group (4.7 ± 2.7 vs. 4.8 ± 2.8, SMD=-0.036, 95%CI=-0.325 – 
0.253, p=0.806), although only one study was included in the RBA group. Potential publication 
bias was not significant, as confirmed by the Begg analysis (Kendall’s tau = 0.267, p=0.452) and 
the Egger regression test (z= 0.590, p=0.587). However, the incidence of CLN metastasis was 
comparable between RT and OT (37.1% vs. 36.9%, OR=1.035, 95%CI=0.842 – 1.272, p=0.745). 
In terms of TNM stages, the ratio for Stages I&II / Stages III&IV tumors for RT and OT were 
2.49 and 1.03, respectively (OR=0.456, 95%CI=0.285 – 0.729, p=0.001) and proportion of stage 
I tumors was significantly more in RT than OT (71.2% vs. 50.2%, p<0.001). 
Oncological outcomes 
Table 3 shows a comparison of RAI ablation, postoperative sTg levels, post-therapy findings and 
LRR between RT and OT. Percentages of RAI ablation were given in 5 studies [14,15,23,24,27]. 
The percentage of RAI ablation in RT ranged from 25.0% to 100% while RAI ablation in OT 
ranged from 36.7% to 100%. Their dose ranged from 2.78 to 5.55 GBq. Overall, the proportion 
receiving RAI ablation was comparable between RT and OT (329/360 (92.7%) vs. 821/945 
(87.7%) (OR=0.952, 95%CI=0.574 – 1.579, p=0.849). Three studies [15,24,27] specifically 
provided and compared the percentage of RAIU at the RxWBS. Two studies [15,24] found 
comparable RAIU at RxWBS while one recent study found RAIU at RxWBS was significantly 
higher in the RT group (0.10 vs. 0.05, p=0.002) [27]. 
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Six studies [14,15,22,23,26,27] compared pre-ablation sTg levels between the two groups. One 
study [23] also had post-ablation sTg levels while another study [24] only reported non-
stimulated Tg levels. Figure 2b shows the forest plot for pre-ablation sTg. The overall mean pre-
ablation sTg was significantly higher in RT than that in OT (3.6 ± 6.7ng/mL vs. 2.0 ± 5.0ng/mL, 
SMD=0.272, 95%CI=0.022 – 0.522, p=0.033). When only RTAA was considered, the difference 
became more significant between the two groups (6.1 ± 9.0ng/mL vs. 2.5 ± 5.8ng/mL, 
SMD=0.428, 95%CI=0.276 – 0.580, p<0.001) while when only RBA was considered, sTg 
appeared comparable (1.2 ± 3.4ng/mL vs. 1.1 ± 2.7ng/mL, SMD=0.040, 95%CI=-0.122 – 0.202, 
p=0.632). After a mean follow-up of 17.7 ± 8.7 months in RT group, no recurrence was found in 
RT group and after a mean follow-up of 18.6 ± 8.8 months, 1 recurrence was found in the OT 
group. There was no significant difference in mean follow-up between the two groups (p=0.860).  
Sensitivity analysis 
Since there were significant differences in study design and size, sensitivity analyses were 
performed. Findings on extrathyroidal extension, multicentricity, bilaterality, tumor size, CLN 
metastases, TNM stages, RAI and RxWBS were similar when the two prospective studies [26,27] 
were excluded or when the two small studies [21,24] were excluded from the pooled data. 
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DISCUSSION 
Although RT may have the benefits of superior cosmesis and improved patient satisfaction,[2-4] 
it remains a controversial procedure in the West [10] Apart from the higher procedural cost, 
surgical completeness and oncological safety with RT have not been fully addressed [10,32] 
Although previous studies have demonstrated comparable completeness between RT and OT, 
they were single-institution studies.[14,15] Our data showed that RT seemed to be less effective 
in complete removal of thyroid tissue. This point should be kept in mind when a surgeon has to 
decide for the type of operation especially in high-risk groups such as older males, or patients 
with a posteriorly-located carcinoma or history of radiotherapy.  
Despite the increasing number of publications comparing outcomes between the two procedures, 
all eligible studies were non-randomized and were subjected to selection biases. This was evident 
when patient baseline characteristics were being pooled. Patients in RT were significantly 
younger (40.8 years old vs. 50.3 years old, p<0.001) and more likely to be female (92.8% vs. 
86.5%, p<0.001). Also overall the tumors in RT were significantly smaller (7.7 ± 3.3mm and 8.6 
± 4.6mm, p<0.001) and earlier staged (p<0.001). Therefore, based on these findings, tumors in 
RT belonged to a better risk group and so to some extent, RT was expected to have a more 
complete surgical resection and better oncological outcome than OT. However, our data shows 
that RT may be associated with a less complete resection than OT. Of the 6 studies 
[14,15,22,23,26,27] comparing pre-ablation sTg levels, RT had significantly higher mean level 
than OT (3.6ng/mL vs. 2.0ng/mL, p<0.001) implying that greater amount of residual thyroid 
tissue was left after surgery. Interestingly, this difference was only found in the RTAA group 
(6.1ng/mL vs. 2.5ng/mL, p<0.001) and not in the RBA group (1.2ng/mL vs. 1.1ng/mL, p=0.632). 
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One study also found that the percentage of RAIU on RxWBS after RTAA was also significantly 
higher than that of the OT (0.10 vs. 0.05, p=0.002) [27]. These findings are in discordant to 
previous single-institution studies which found the surgical completeness was comparable 
between RT and OT [14,15] However, it is worth noting that this was only for patients who 
underwent TT because both sTg and RAIU only reflect the amount of residual thyroid remnant 
after TT and not LTT. We postulate that one reason why TT by RTAA might be associated with 
a less complete thyroid resection is because during RTAA, the surgeon often has difficulty 
completely removing the contralateral lobe (or the non-tumorous side) when the incision is 
placed in the opposite axilla [7]. Therefore, we think the most likely source of pre-ablation sTg 
after RTAA is from the contralateral thyroid remnant and not from the ipsilateral lobe or residual 
tumor tissue. However, in terms of oncological clearance, we do not believe RTAA would 
compromise the oncological outcome. This is especially when most of these procedures were 
done for papillary microcarcinoma and low-risk DTC and so leaving small amount of non-
tumorous thyroid tissue is unlikely to compromise prognosis when the oncological outcome is 
already excellent. This is supported by the fact that  in one particular study, despite the higher 
initial pre-ablation level, the post-ablation sTg levels became comparable after 9-12 months 
(1.73ng/mL vs. 1.55ng/mL, p=0.661) [23]. 
Another measurement of surgical completeness was the number of CLNs retrieved during 
concomitant CND. RT had significantly fewer CLNs retrieved during CND than OT (4.7 vs. 5.5, 
p<0.001). Although the absolute difference was small (<1 CLN), it was nevertheless statistically 
significant. Interestingly, this difference was again more evident in RTAA (4.7 vs. 5.7, p<0.001) 
than RBA (4.7 vs. 4.8, p=0.806). We believe this might be attributed to a combination of factors. 
One factor is the difference in surgical approach because RTAA is essentially a lateral approach 
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while OT is a medial or midline approach. Nevertheless, since the incidence of CLN metastasis 
was comparable (37.1% vs. 36.9%, p=0.745), we do not believe that RTAA had significantly 
under-staged the nodal status of DTCs at the time of operation. However, it was difficult to know 
if these concomitant CNDs were done prophylactically or therapeutically as none of the studies 
stated this. Regarding the comparison of actual oncological outcome, given that there was only 
one LRR detected in both groups in a relatively short follow-up period, it was difficult to exactly 
know if there is really a difference in outcome between RT and OT.  
Despite some interesting findings, there are several shortcomings which need acknowledgement. 
Firstly, since all eligible studies were non-randomized or of low quality (≤4 by NOS), selection 
biases could have accounted for some of the differences in surgical completeness. Furthermore, 
it is unclear whether some studies were truly measuring the same outcome (e.g. sTg or RxWBS). 
Secondly, the number of studies eligible for inclusion was relatively small. Since there was 
significant overlap in dataset between studies and one-fourth of eligible studies were excluded 
(see Table 1). Nevertheless, excluding the two smallest studies did not affect our results. Thirdly, 
given the very good prognosis (and low risk for LRR) in DTCs, a much larger cohort with 
significant longer follow-up is necessary to fully evaluate the oncological outcome of RT. 
Nevertheless, if one considers pre-ablation sTg level and the percentage of RAIU on RxWBS as 
surrogates for surgical completeness, it would appear that TT via the RTAA has less complete 
thyroid resection than TT via the open approach. Lastly, although assessment of publication bias 
was performed, non-significant p-values do not necessarily imply no publication bias as the 
number of included studies was relatively small (i.e. low power to detect a real difference). 
Conclusion 
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Despite the significantly fewer number of CLNs retrieved in CND and less complete TT by 
RTAA, RTAA is unlikely to compromise the oncological outcome of patients with low-risk DTC. 
However, given the excellent prognosis with few recurrences in low-risk DTC, a much larger 
patient cohort with long prospective follow up is necessary to fully evaluate the oncological 
outcome of RT in the future. 
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Table 1. The ten articles which were excluded after reviewing the full-length text 
First Author Journal Publication 
year, country 
Title Main reason for exclusion 
Kang[28] Surgical Endoscopy 2009, Korea Robot-assisted endoscopic surgery for 
thyroid cancer: experience with the first 
100 patients 
 
Data from this study were 
included in a later study[22] 
 
Lee[29] Annals of Surgical 
Oncology 
2011, Korea Multicenter study of robotic 
thyroidectomy: short-term postoperative 
outcomes and surgeon ergonomic 
considerations. 
There was no open 
thyroidectomy group for 
comparison. 
     
Tae[30] Surgical Endoscopy 2011, Korea Robotic thyroidectomy by a gasless 
unilateral axillo-breast or axillary 
approach: our early experience 
 
Data from this study were 
included in a later study[23] 
Broome[31] Archives of Surgery 2012, USA Expense of robotic thyroidectomy: a cost 
analysis at a single institution 
This study did not compare 
outcomes between robotic 
and open approaches 
 
Cabot[32] Surgery 2012, USA Robotic and endoscopic transaxillary 
thyroidectomies may be prohibitive 
when compared to standard cervical 
thyroidectomy: a cost analysis 
 
This study did not compare 
outcomes between robotic 
and open approaches 
 
 
Foley[33] Surgical Endoscopy  2012, USA Robotic transaxillary endocrine surgery: 
a comparison with conventional open 
technique 
 
Data from this study were 
included in a later study[24] 
Lee[34] Annals of Surgical 
Oncology 
2012, Korea Postoperative functional voice changes 
after conventional open or robotic 
Data from this study were 
included in an earlier but 
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thyroidectomy: a prospective trial 
 
more representative 
study[19] 
 
Tae[35] Surgical Endoscopy  2012, Korea Functional voice and swallowing 
outcomes after robotic thyroidectomy by 
a gasless unilateral axillo-breast 
approach: comparison with open 
thyroidectomy 
 
Data from this study were 
included in a later study[23] 
Yoo[36] Surgical Endoscopy 2013, Korea Comparison of the incidence of 
postoperative nausea and vomiting 
between women undergoing open or 
robot-assisted thyroidectomy 
 
No oncological outcomes 
were reported 
Kim[37] Surgical Endoscopy 2013, Korea Influence of carbon dioxide insufflation 
of the neck on intraocular pressure 
during robot-assisted endoscopic 
thyroidectomy: a comparison with open 
thyroidectomy. 
No oncological outcomes 
were reported 
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Table 2a. A comparison of patient characteristics between robotic assisted thyroidectomy (RT) and open thyroidectomy (OT). Studies 
were grouped according to robotic approaches. 
First 
author 
(year) 
Type Number of patients Mean age (±SD) 
(yrs) 
Sex ratio 
(Male:Female) 
Histological type Study 
quality# 
RT OT RT OT RT OT RT OT 
TT LTT TT LTT 
Robotic transaxillary approach (RTAA) 
Lee 
(2010) 
[20] 
RS 26 15 26 17 39.0 ± 
7.0 
37.7 ± 
6.5 
3:38 3:40 PTC = 41 
FTC = 0 
PTC = 43 
FTC = 0 
3 
Landry 
(2012) 
[21] 
RS 0 4 0 3 *50 (22 
-62) 
*53 (24 
-75) 
0:4 0:3 PTC = 3 
FTC = 1 
PTC = 2 
FTC = 1 
2 
Lee 
(2012) 
[22] 
RS 27 165 90 176 41.9 ± 
9.2 
48.7 ± 
10.8 
13:179 53:213 PTC = 192 
FTC = 0 
PTC = 266 
FTC = 0 
4 
Tae 
(2012) 
[23] 
RS 29 46 204 22 39.6 ± 
8.9 
51.0 ± 
12.5 
5:70 37:189 PTC = 75 
FTC = 0 
PTC = 226 
FTC = 0 
3 
Aliyev 
(2013)  
RS 11 0 21 0 48 ± 4 51 ± 3 0:11 1:20 PTC = 10 
FTC = 1 
PTC = 20 
FTC = 1 
2 
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[24] 
Ryu 
(2013) 
[25] 
RS 45 0 45 0 39.0 ± 
7.8 
48.9 ± 
10.3 
3:42 9:36 PTC = 45 
FTC = 0 
PTC = 45 
OT = 0 
3 
Yi (2013) 
[14] 
RS 98 0 423 0 42.2 ± 
8.2 
51.8 ± 
10.5 
0:98 0:423 PTC = 98 
FTC = 0 
PTC = 423 
FTC = 0 
4 
Lee 
(2013) 
[27] 
PS 43 0 51 0 39.8 ± 
10.2 
48.3 ± 
10.6 
NR NR PTC = 43 
FTC = 0 
PTC = 51 
FTC = 0 
4 
RTAA 
overall 
- 279 230 860 218 41.1 ± 
8.7 
50.0 ± 
10.8 
24:427 102:90
1 
PTC = 507 
FTC =2 
PTC= 1076 
FTC = 2 
 
Robotic bilateral axillo-breast approach (RBA) 
Kim 
(2011) 
[26] 
PS 69 0 138 0 41.3 ± 
7.8 
51.8 ± 
8.9 
6:63 34:104 PTC = 69 
FTC = 0 
PTC= 138 
FTC = 0 
4 
Lee 
(2011) 
[15] 
RS 174 0 237 0 39.9 ± 
8.8 
51.1 ± 
11.1 
20:154 50:187 PTC = 174 
FTC = 0 
PTC = 237 
FTC = 0 
4 
RBA 
subtotal 
- 243 0 375 0 40.3 ± 
8.5 
51.4 ± 
10.3 
26:217 84:291 PTC = 243 
FTC = 0 
PTC = 375 
FTC = 0 
 
Overall - 522 230 1235 218 40.8 ± 50.3 ± 50:644 186:11 PTC = 750 PTC= 1451  
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8.6 10.7 92 FTC = 2 FTC = 2 
Matching: 1 = age; 2 = sex; 3 = body mass index (BMI); 4 = histology; 5 = extent of thyroidectomy 
*only the median and range were provided 
Abbreviations: PS = prospective study; RS = retrospective study; NR = not reported; TT = total thyroidectomy; LTT = less than total 
thyroidectomy; PTC = papillary thyroid carcinoma; FTC = follicular thyroid carcinoma 
# using the Newcastle–Ottawa Scale 
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Table 2b. A comparison of tumor characteristics between robotic assisted thyroidectomy (RT) and open thyroidectomy (OT). Studies 
were grouped according to robotic approaches. 
First 
author 
(year) 
Extra-
thyroidal 
(%) 
Multi-
centricity (%) 
Bilaterality 
(%)+ 
Mean tumor 
size (mm) 
Number of CLNs 
retrieved (extent of 
CND) 
CLN 
metastasis (%) 
7th edition 
TNM stage 
(I/II/III/IV) 
RT OT RT OT RT OT RT OT RT OT RT OT RT OT 
Robotic transaxillary approach (RTAA) 
Lee 
(2010) 
[20] 
NR NR 10 
(24.4) 
9 
(20.9) 
3 
(11.5) 
5 
(19.2) 
8.3 ± 
2.7 
8.9 ± 
3.0 
4.4 ± 2.1 
(UL) 
4.3 ± 2.9 
(UL) 
18 
(43.9) 
19 
(44.2) 
37/0/
4/0 
38/0/
5/0 
Landry 
(2012) 
[21] 
NR NR NR NR NR NR 6.6 ± 
7.7 
7.0 ± 
7.2 
NR (no 
CND) 
NR (no 
CND) 
NR NR 4/0/0/
0 
3/0/0/
0 
Lee 
(2012) 
[22] 
86 
(44.8) 
131 
(49.2) 
47 
(24.5) 
79 
(29.7) 
22 
(81.5) 
49 
(54.4) 
6 ± 2.1 6 ± 2.1 4.6 ± 3.5 
(UL) 
5.7 ± 4.3 
(UL) 
49 
(25.5) 
66 
(24.8) 
150/0
/42/0 
167/0
/96/3 
Tae 
(2012) 
[23] 
29 
(38.6) 
93 
(41.2) 
10 
(13.3) 
72 
(31.9) 
2 
(6.9) 
51 
(25.0) 
8.1 ± 
4.7 
9.9 ± 
6.4 
4.3 ± 2.4 
(UL) 
5.5 ±3.3 
(UL) 
26/57 
(45.6) 
64/153 
(41.8) 
60/0/
15/0 
142/5
/77/2 
Aliyev 
(2013) 
NR NR NR NR NR NR 18 ± 3 18 ± 2 NR (no 
CND) 
NR (no 
CND) 
NR NR 9/1/1/
0 
17/1/
3/0 
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[24] 
Ryu 
(2013) 
[25] 
NR NR 3 
(6.7) 
11 
(24.4) 
13 
(28.9) 
18 
(40.0) 
9.6 ± 
3.6 
11.8 ± 
6.2 
5.7 ± 4.8 
(UL) 
7.0 ± 5.2 
(UL) 
13 
(28.9) 
16 
(35.6) 
NR NR 
Yi 
(2013) 
[14] 
63 
(64.3) 
267 
(63.1) 
34 
(34.7) 
164 
(38.8) 
24 
(24.5) 
97 
(22.9) 
*8 (1 – 
19) 
*8 (1 – 
20) 
*6.5 (0 – 
4) (UL) 
*7.0 (0 – 
28) (UL) 
36 
(36.7) 
160 
(37.8) 
67/0/
31/0 
183/0
/240/
0 
Lee 
(2013) 
[27] 
39 
(90.7) 
41 
(80.4) 
18 
(41.9) 
15 
(29.4) 
15 
(34.9) 
13 
(25.5) 
10.1 ± 
4.6 
10.6 ± 
7.1 
4.9 ± 2.9 
(UL) 
6.3 ± 4.2 
(UL) 
17 
(39.5) 
27 
(52.9) 
31/0/
12/0 
22/0/
29/0 
RTAA 
subtotal 
217 
(53.2) 
532 
(55.1) 
122 
(24.7) 
350 
(33.2) 
79 
(29.5) 
233 
(27.8) 
7.9 ± 
3.3 
8.8 ± 
4.8 
4.7 ± 
3.3# 
5.7 ± 
4.0# 
159 
(33.4) 
352 
(35.9) 
331/1
/132/
0 
560/6
/462/
5 
Robotic bilateral axillo-breast approach (RBA) 
Kim 
(2011) 
[26] 
NR NR NR NR NR NR 6 ± 2 7 ± 2 4.7 ± 2.7 
(UL) 
4.8 ± 2.8 
(UL) 
NR NR NR NR 
Lee 
(2011) 
[15] 
131 
(75.3) 
178 
(75.1) 
78 
(44.8) 
88 
(37.1) 
42 
(24.1) 
43 
(18.1) 
8 ± 3.6 9 ± 4.9 NR (UL) NR (UL) 82 
(47.1) 
97 
(40.9) 
123/0
/51/0 
78/1/
158/0 
RBA 131 178 78 88 42 43 7.4 ± 8.3 ± 4.7 ± 4.8 ± 82 97 123/0 78/1/
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subtotal (75.3) (75.1) (44.8) (37.1) (24.1) (18.1) 3.2 4.1 2.7# 2.8# (47.1) (40.9) /51/0 158/0 
Total 348 
(59.8) 
710 
(59.0) 
200 
(29.9) 
438 
(33.9) 
121 
(27.4) 
276 
(25.7) 
7.7 ± 
3.3 
8.6 ± 
4.6 
4.7 ± 
3.2# 
5.5 ± 
3.8# 
241 
(37.1) 
449 
(36.9) 
454/1
/183/
0 
638/7
/620/
5 
p-value 0.732 0.368 0.721 <0.001 <0.001 0.745 0.001 
* only the median and range were available 
# only unilateral CND was analyzed 
+ percentages were calculated based on total number of total thyroidectomies 
Abbreviation: NR = not reported; CND = central neck dissection; UL = unilateral 
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Table 3. A comparison of postoperative stimulated thyroglobulin levels and locoregional recurrence between robotic-assisted 
thyroidectomy (RT) and open thyroidectomy (OT). Studies were grouped according to robotic approaches 
First author 
(year) 
Number of 
carcinoma 
 RAI ablation 
(%)+ 
Pre-ablation sTg 
level (ng/ml) 
Post-therapy scan 
findings  
LRR (%) Mean follow-up 
(months) 
RT OT RT OT RT OT RT OT RT OT RT OT 
Robotic trans-axillary approach (RTAA) 
Lee (2012) 
[22]^ 
192 266 NR NR 0.25 0.22 No 
abnormal 
uptake 
No 
abnormal 
uptake 
0 (0.0) 0 (0.0) 29.1 29.1 
Tae (2012) 
[23] 
75 226 20 
(69.0) 
159 
(77.9) 
12.7± 
15.0 
4.9 ± 
8.6  
NR NR 0 (0.0) 0 (0.0) 11.2 12.5 
Aliyev (2013) 
[24] 
11 21 4 (36.4) 11 
(52.4) 
1.0 ± 
0.5* 
1.0 ± 
0.7* 
0.65 ± 
0.30## 
0.84 ± 
0.20## 
0 (0.0) 0 (0.0) 9.0 9.0 
Yi (2012) 
[14]^ 
98 423 88 
(89.8) 
363 
(85.8) 
2.1 ± 
3.8 
1.1 ± 
4.2 
NR NR 0 (0.0) 1 (0.2) 27.4 28.8 
Lee (2013) 
[27] 
43 51 43 (100) 51 (100) 4.9 ± 
1.4 
4.2 ± 
1.2 
0.10 ± 
0.01# 
0.05 ± 
0.01# 
0 (0.0) 0 (0.0) 12 12 
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RTAA 
subtotal 
419 987 155 
(85.6) 
584 
(83.5) 
6.1 ± 
9.0 
2.5 ± 
5.8 
0.15 ± 
0.08 
0.19 ± 
0.08 
0 (0.0) 1 (0.2) 17.7 ± 
9.7 
18.3 ± 
9.8 
Robotic bilateral axillo-breast approach (RBA) 
Kim (2011) 
[26] 
69 138 NR NR 0.8 ± 
1.4 
0.8 ± 
2.0 
NR NR NR NR NR NR 
Lee (2011) 
[15]^ 
174 237 174 
(100) 
237 
(100) 
1.4 ± 
3.9 
1.2 ± 
3.1 
12.8 ± 
13.3# 
13.5 ± 
13.3# 
0 (0.0) 0 (0.0) 17.3 19.9 
RBA subtotal 243 375 174 
(100.0) 
237 
(100.0) 
1.2 ± 
3.4 
1.1 ± 
2.7 
12.8 ± 
13.3# 
13.5 ± 
13.3# 
0 (0.0) 0 (0.0) 17.3 19.9 
Total 662 1362 329 
(92.7) 
821 
(87.7) 
3.6 ± 
6.7 
2.0 ± 
5.0 
10.1 ± 
11.8 
10.7 ± 
11.9 
0 (0.0) 1 (0.2) 17.7 ± 
8.7 
18.6 ± 
8.8 
p-value - 0.849 0.033 0.453 - 0.860 
Abbreviations: RAI = radioactive iodine; LRR = locoregional recurrence; sTg = stimulated thyroglobulin; NR = not reported  
+ percentages were calculated based on total number of total thyroidectomies 
*mean non-stimulated levels; # thyroid bed-to-background ratio;## percentage uptake of RAI 
^studies which had been verified with the corresponding author 
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Figure legends 
 
Figure 1. A flow diagram for study selection 
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Figure 2a. A forest plot for number of central lymph nodes retrieved in robotic thyroidectomy 
(RT) and open thyroidectomy (OT); Figure 2b. A forest plot for pre-ablation stimulated 
thyroglobulin (sTg) level in robotic total thyroidectomy (RT) and open thyroidectomy (OT) 
